Signal active
Bio
Arie Belldegrun is the Co-Founder and Chairman of Bellco Capital, a Co-Chairman at Breakthrough Properties, an Executive Chairman and Co-Founder at Allogene Therapeutics, the Founder, Chairman, President, and CEO of Kite Pharma, and the Chairman and Partner at Two River. He attended Hadassah Medical School and Harvard Medical School.
Location
Los Angeles, California, United States, North America
Social
Primary Organization
2003
15
0
6
1-10
Financial Services
Jobs history
5
Bellco Capital
Co-Founder and Chairman
Invalid date - Current
IconOVir Bio
Board Member
2021 - Current
Chairman Of The Board
2017 - Current
Founding Partner
2017 - Current
Breakthrough Properties
Co Chairman
2018 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Arie Belldegrun is the Co-Founder and Chairman at Bellco Capital, based in United States, North America. With a background in Financial Services, Arie Belldegrun has a rich history of leadership and innovation. Arie Belldegrun studied MD unknown @ The Hebrew University Hadassah Medical School. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
2
3
Personal investment
2
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
May 02, 2014 | Kite Pharma | Debt Financing - Kite Pharma | 50.0M |
Aug 16, 2016 | Arno Therapeutics | Post-IPO Equity - Arno Therapeutics | 8.0M |
Partner investment
3
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Apr 19, 2018 | - | Series A - Allogene Therapeutics | - | 411.8M |
Apr 15, 2020 | ByHeart | Series A - ByHeart | Bellco Capital | 70.0M |
May 13, 2024 | ByHeart | Series C - ByHeart | Bellco Capital | 95.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.